Daniel Janney, Director at VIVEVE MEDICAL, INC. (VIVE), bought 500,000 shares at $4.00 ($2.0M) on 2017-03-17, disclosed to the SEC on 2017-03-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KRYS | SELL | 2023-06-09 | $8.3M | — | Filing → |
| KRYS | SELL | 2023-05-23 | $4.8M | — | Filing → |
| KRYS | SELL | 2023-05-11 | $1.6M | — | Filing → |